ALLERGAN (COSTA RICA)
Manufacturer adverse-event records for ALLERGAN come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2011–2026 · heavy-book · quiet Death-code · injury-heavy
Volume signature
ALLERGAN sits in the heavy MAUDE book
ALLERGAN (COSTA RICA) accounts for 179,944 FDA MAUDE reports (#18 of 434, heavy-book tercile). Death-coded event_type share is 0.04% (quiet); Injury share 99.4% (injury-heavy).
What the volume reading shows for ALLERGAN (COSTA RICA)
The standout signal for ALLERGAN (COSTA RICA) is filing volume: 179,944 adverse-event reports in FDA MAUDE (#18 of 434, heavy-book). Death-coded event_type share sits at 0.04% (quiet).
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair ALLERGAN with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 8 device types, led in this extract by Injury at 178,784 (99.4% of event_type total). Peak single-year volume reaches 26,414 reports across 15 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (8)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.